Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. | KMTS | $25.54 | $1.50B | — | |
| agilon health, inc. | AGL | $88.50 | $1.49B | — | |
| Vor Biopharma Inc. | VOR | $25.05 | $1.48B | 0.1 | — |
| CONMED Corporation | CNMD | $49.32 | $1.48B | 26.8 | 1.62% |
| Mind Medicine (MindMed) Inc. | MNMD | $18.09 Mar 17, 2026 | $1.46B | — | |
| Alphatec Holdings, Inc. | ATEC | $9.45 | $1.46B | — | |
| InnovAge Holding Corp. | INNV | $10.75 | $1.46B | — | |
| Maze Therapeutics, Inc. | MAZE | $26.21 | $1.46B | — | |
| Immatics N.V. | IMTX | $9.56 | $1.46B | — | |
| First Tracks Biotherapeutics, Inc. | TRAX | $40.46 | $1.45B | — | |
| Harrow, Inc. | HROW | $38.54 | $1.44B | — | |
| Alumis Inc. | ALMS | $11.10 | $1.44B | — | |
| KalVista Pharmaceuticals, Inc. | KALV | $27.00 Jun 12, 2026 | $1.43B | — | |
| Replimune Group, Inc. | REPL | $15.04 | $1.42B | — | |
| Alto Neuroscience, Inc. | ANRO | $35.55 | $1.40B | — | |
| Omada Health, Inc. | OMDA | $22.77 | $1.39B | 33.0 | — |
| Alpha Tau Medical Ltd. | DRTS | $15.03 | $1.39B | — | |
| Tandem Diabetes Care, Inc. | TNDM | $19.90 | $1.38B | — | |
| Odyssey Therapeutics, Inc. | ODTX | $28.76 | $1.38B | — | |
| Azenta, Inc. | AZTA | $31.33 | $1.37B | — | |
| Omeros Corporation | OMER | $18.95 | $1.37B | 11.5 | — |
| Cullinan Therapeutics, Inc. | CGEM | $22.09 | $1.36B | — | |
| MeiraGTx Holdings plc | MGTX | $13.89 | $1.33B | 16.0 | — |
| ORIC Pharmaceuticals, Inc. | ORIC | $12.86 | $1.33B | — | |
| Seaport Therapeutics, Inc. | SPTX | $24.86 | $1.33B | — | |
| The Pennant Group, Inc. | PNTG | $38.00 | $1.33B | 42.2 | — |
| Nutex Health Inc. | NUTX | $193.24 | $1.32B | 7.5 | — |
| AMN Healthcare Services, Inc. | AMN | $33.80 | $1.31B | 12.6 | — |
| MannKind Corporation | MNKD | $4.06 | $1.31B | — | |
| Integra LifeSciences Holdings Corporation | IART | $16.72 | $1.30B | — | |
| PROCEPT BioRobotics Corporation | PRCT | $22.76 | $1.30B | — | |
| MoonLake Immunotherapeutics | MLTX | $15.01 | $1.28B | — | |
| Jade Biosciences, Inc. | JBIO | $19.90 | $1.27B | — | |
| Artivion, Inc. | AORT | $25.57 | $1.25B | — | |
| Janux Therapeutics, Inc. | JANX | $20.24 | $1.24B | — | |
| OPKO Health, Inc. | OPK | $1.64 | $1.22B | — | |
| Certara, Inc. | CERT | $7.94 | $1.21B | — | |
| Corvus Pharmaceuticals, Inc. | CRVS | $14.39 | $1.21B | — | |
| Cronos Group Inc. | CRON | $3.26 | $1.20B | 17.2 | — |
| GoodRx Holdings, Inc. | GDRX | $3.48 | $1.19B | 58.0 | — |
| U.S. Physical Therapy, Inc. | USPH | $79.35 | $1.18B | 466.8 | 2.34% |
| Monte Rosa Therapeutics, Inc. | GLUE | $13.84 | $1.18B | — | |
| Kura Oncology, Inc. | KURA | $13.25 | $1.18B | — | |
| STAAR Surgical Company | STAA | $23.47 | $1.18B | 293.4 | — |
| Avanos Medical Inc | AVNS | $24.99 Jul 24, 2026 | $1.17B | — | |
| Lumexa Imaging Holdings, Inc. | LMRI | $12.18 | $1.17B | — | |
| Attovia Therapeutics, Inc. | ATTO | $25.55 | $1.17B | — | |
| Sana Biotechnology, Inc. | SANA | $3.85 | $1.15B | — | |
| Apnimed, Inc. | APMD | $27.45 | $1.14B | 11.4 | — |
| Teladoc Health, Inc. | TDOC | $6.28 | $1.14B | — |
Kestra Medical Technologies, Ltd.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.50B
- P/E
- unprofitable
agilon health, inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.49B
- P/E
- unprofitable
Vor Biopharma Inc.
Healthcare / Biotechnology
- Market Cap
- $1.48B
- P/E
- 0.1
CONMED Corporation
Healthcare / Medical Devices
- Market Cap
- $1.48B
- P/E
- 26.8
- Dividend Yield
- 1.62%
Mind Medicine (MindMed) Inc.
Healthcare / Biotechnology
- Market Cap
- $1.46B
- P/E
- unprofitable
Alphatec Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.46B
- P/E
- unprofitable
InnovAge Holding Corp.
Healthcare / Medical Care Facilities
- Market Cap
- $1.46B
- P/E
- unprofitable
Maze Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.46B
- P/E
- unprofitable
Immatics N.V.
Healthcare / Biotechnology
- Market Cap
- $1.46B
- P/E
- unprofitable
First Tracks Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.45B
- P/E
- unprofitable
Harrow, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.44B
- P/E
- unprofitable
Alumis Inc.
Healthcare / Biotechnology
- Market Cap
- $1.44B
- P/E
- unprofitable
KalVista Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.43B
- P/E
- unprofitable
Replimune Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.42B
- P/E
- unprofitable
Alto Neuroscience, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.40B
- P/E
- unprofitable
Omada Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.39B
- P/E
- 33.0
Alpha Tau Medical Ltd.
Healthcare / Biotechnology
- Market Cap
- $1.39B
- P/E
- unprofitable
Tandem Diabetes Care, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.38B
- P/E
- unprofitable
Odyssey Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.38B
- P/E
- unprofitable
Azenta, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.37B
- P/E
- unprofitable
Omeros Corporation
Healthcare / Biotechnology
- Market Cap
- $1.37B
- P/E
- 11.5
Cullinan Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.36B
- P/E
- unprofitable
MeiraGTx Holdings plc
Healthcare / Biotechnology
- Market Cap
- $1.33B
- P/E
- 16.0
ORIC Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.33B
- P/E
- unprofitable
Seaport Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.33B
- P/E
- unprofitable
The Pennant Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.33B
- P/E
- 42.2
Nutex Health Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.32B
- P/E
- 7.5
AMN Healthcare Services, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.31B
- P/E
- 12.6
MannKind Corporation
Healthcare / Biotechnology
- Market Cap
- $1.31B
- P/E
- unprofitable
Integra LifeSciences Holdings Corporation
Healthcare / Medical Devices
- Market Cap
- $1.30B
- P/E
- unprofitable
PROCEPT BioRobotics Corporation
Healthcare / Medical Devices
- Market Cap
- $1.30B
- P/E
- unprofitable
MoonLake Immunotherapeutics
Healthcare / Biotechnology
- Market Cap
- $1.28B
- P/E
- unprofitable
Jade Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.27B
- P/E
- unprofitable
Artivion, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.25B
- P/E
- unprofitable
Janux Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.24B
- P/E
- unprofitable
OPKO Health, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.22B
- P/E
- unprofitable
Certara, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.21B
- P/E
- unprofitable
Corvus Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.21B
- P/E
- unprofitable
Cronos Group Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.20B
- P/E
- 17.2
GoodRx Holdings, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.19B
- P/E
- 58.0
U.S. Physical Therapy, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.18B
- P/E
- 466.8
- Dividend Yield
- 2.34%
Monte Rosa Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.18B
- P/E
- unprofitable
Kura Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.18B
- P/E
- unprofitable
STAAR Surgical Company
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.18B
- P/E
- 293.4
Avanos Medical Inc
Healthcare / Medical Devices
- Market Cap
- $1.17B
- P/E
- unprofitable
Lumexa Imaging Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.17B
- P/E
- unprofitable
Attovia Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.17B
- P/E
- unprofitable
Sana Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.15B
- P/E
- unprofitable
Apnimed, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.14B
- P/E
- 11.4
Teladoc Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.14B
- P/E
- unprofitable
Showing 351–400 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.